Table 5.
Sub-analysis based on blood product resuscitation ratio (1:1:1 vs. 1:1:2)
| 1:1:1 Blood Product | No-TXA (n=29) |
TXA (n=17) |
P-value |
|---|---|---|---|
| Mortality, % | |||
| 6-hour | 34% | 17% | 0.31 |
| 12-hour | 38% | 35% | 0.76 |
| 18-hour | 38% | 35% | 0.76 |
| 24-hour | 38% | 41% | 0.82 |
| 30-day | 48% | 47% | 0.93 |
| Time to achieve hemostasis, min [IQR] | 128 [53–235] | 138 [49 ─ 313] | 0.65 |
| 1:1:2 Blood Product |
No-TXA (n=33) |
TXA (n=14) |
P-value |
| Mortality, % | |||
| 6-hour | 33% | 7% | 0.07 |
| 12-hour | 33% | 7% | 0.07 |
| 18-hour | 39% | 7% | 0.03 |
| 24-hour | 42% | 7% | 0.02 |
| 30-day | 52% | 42% | 0.55 |
| Time to achieve hemostasis, min [IQR] | 157 [74 ─ 219] | 98 [62 ─ 245] | 0.48 |
Min=Minutes, IQR=Interquartile Range